Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Benralizumab, Atc R03Dx10 For The Time 01.06.2025 - 31.2027

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 107497512

  Document Type - Tender Notices

Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to include framework discount contracts for the drugs to be issued at the expense of the statutory health insurance companies. With regard to the relevant legal regulations on the awarding of public orders, a regular process of active ingredient, formal award procedures takes place according to the regulations of the 4th part of the GWB through DAK health. For medicines to be named by the bidder in Appendix 2 to the contract to the above. The active ingredient, Benralizumab, ATC R03DX10, intends to conclude the DAK health until the entry into force of new pharmaceutical discount contra

Gt Ref Id - 107497512

Deadline - Apr 05, 2027